findmyKOL
Clinical trialNCT00002705CompletedPhase 1Interventional

Topotecan in Treating Children With Refractory Leukemia

SponsorNational Cancer Institute (NCI)Enrollment3Leukemia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Hopital Sainte Justine

    Montreal, Quebec, Canada

  • Montreal Children'S Hospital

    Montreal, Quebec, Canada

Puerto Rico
  • University of Puerto Rico School of Medicine Medical Sciences Campus

    San Juan, Puerto Rico

Switzerland
  • Clinique de Pediatrie

    Geneva, Switzerland

United States
  • University of Alabama Comprehensive Cancer Center

    Birmingham, Alabama, United States

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas, United States

  • University of California San Diego Cancer Center

    La Jolla, California, United States

  • Lucile Packard Children'S Hospital at Stanford

    Palo Alto, California, United States

  • Shands Hospital and Clinics, University of Florida

    Gainesville, Florida, United States

  • Emory University Hospital - Atlanta

    Atlanta, Georgia, United States

  • Children'S Memorial Hospital, Chicago

    Chicago, Illinois, United States

  • University of Kansas Medical Center

    Kansas City, Kansas, United States

  • Via Christi Regional Medical Center

    Wichita, Kansas, United States

  • Mbccop - Lsu Medical Center

    New Orleans, Louisiana, United States

  • Johns Hopkins Oncology Center

    Baltimore, Maryland, United States

  • Boston Floating Hospital Infants and Children

    Boston, Massachusetts, United States

  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

  • Children'S Hospital of Michigan

    Detroit, Michigan, United States

  • Washington University School of Medicine

    St Louis, Missouri, United States

  • Hackensack University Medical Center

    Hackensack, New Jersey, United States

  • Roswell Park Cancer Institute

    Buffalo, New York, United States

  • State University of New York - Upstate Medical University

    Syracuse, New York, United States

  • Memorial Mission Hospital

    Asheville, North Carolina, United States

  • Duke Comprehensive Cancer Center

    Durham, North Carolina, United States

  • Saint Jude Children'S Research Hospital

    Memphis, Tennessee, United States

  • Medical City Dallas Hospital

    Dallas, Texas, United States

  • Simmons Cancer Center - Dallas

    Dallas, Texas, United States

  • Baylor College of Medicine

    Houston, Texas, United States

  • San Antonio Military Pediatric Cancer and Blood Disorders Center

    Lackland Air Force Base, Texas, United States

  • University of Texas Health Science Center at San Antonio

    San Antonio, Texas, United States

  • Midwest Children'S Cancer Center

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 1996
Primary completion
31 Jan 2001
Completion
Last update posted
1 Feb 2013
Registered enrollment
3
Registry id
NCT00002705

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.